title: Role of the FDA in Affordability of Off-Patent Pharmaceuticals.
authors.affiliation: Department of Medicine and Institute of the History of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors.forename: Jeremy A
authors.initials: JA
authors.lastname: Greene
authors.affiliation: Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
authors.forename: Gerard
authors.initials: G
authors.lastname: Anderson
authors.affiliation: Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
authors.forename: Joshua M
authors.initials: JM
authors.lastname: Sharfstein
mesh_terms: D003132:Commerce; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004339:Drug Compounding; D016527:Drug Costs; D004345:Drug Industry; D016568:Drugs, Generic / Q000191:economics / Q000600:supply & distribution; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic